North America is on high alert while ASF vaccine progress continues

Published 2024년 5월 28일

Tridge summary

Leaders in Canada, the US, and Mexico are taking steps to prevent African Swine Fever (ASF) from entering North America, as the disease continues to spread globally, particularly in Europe and Russia. Canada is investing up to $9.6 million CAD in projects to prevent ASF, and the US is hosting forums and offering a dedicated website for awareness. The US is also developing a national certification program to safeguard swine health. The Philippines is in the final stages of trials for an ASF vaccine, and Vietnam is commercially using a vaccine despite concerns. A new pig cell line for growing ASF viruses has been identified in Uganda, and a European project is working on developing an ASF vaccine.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Leaders in Canada, the US and Mexico remain on high alert to prevent entry of African Swine Fever (ASF) into North America, as vaccine advances continue worldwide. The disease continues to plague many countries around the world, including Russia. 14 countries in Europe recorded commercial farm ASF outbreaks in 2023. This is the worst result since 2014, according to the latest annual report of the European Food Safety Authority. Canada’s Ministry of Agriculture and Agri-Food has just announced an investment of up to $9.6 million CAD to fund 29 ‘ASF Industry Preparedness Programme’ projects across 7 provinces. The Canadian Pork Council considers this “crucial and innovative.” Council Chair René Roy stated that the programme’s “proactive approach, underscores our commitment to invest in advanced technologies, rigorous training and collaborative partnerships to fortify our defenses against ASF and other potential threats.” South of the border, the US Department of Agriculture (USDA) ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.